Caseína quinase
As caseína quinases são uma família de proteínas quinases serina/treonina que regulam vários processos celulares, incluindo a reparação do DNA, os ritmos circadianos e a transdução de sinais. Essas quinases estão envolvidas na fosforilação de numerosas proteínas e estão implicadas em doenças como o câncer, distúrbios neurodegenerativos e síndromes metabólicas. Na CymitQuimica, oferecemos uma seleção de inibidores de caseína quinase para apoiar sua pesquisa em transdução de sinais, regulação do ciclo celular e desenvolvimento terapêutico.
Foram encontrados 137 produtos de "Caseína quinase"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
NMS-P715
CAS:NMS-P715 is a highly selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).Fórmula:C35H39F3N8O3Pureza:99.84%Cor e Forma:SolidPeso molecular:676.73Ellagic acid
CAS:Ellagic acid (Gallogen), a thickened tetracyclic natural product, is a potent CK2 inhibitor. Ellagic acid is an antioxidant. Cost-effective and quality-assured.Fórmula:C14H6O8Pureza:97.11% - 99.75%Cor e Forma:Cream Colored Needles From Pyridine 1992)Peso molecular:302.19Silmitasertib sodium salt
CAS:Silmitasertib sodium salt (CX-4945 sodium salt) is a potent and orally bioavailable, highly selective inhibitor of CK2(IC50 of 1 nM, CK2α).Fórmula:C19H11ClN3NaO2Pureza:99.49% - 99.62%Cor e Forma:SolidPeso molecular:371.75Emodin
CAS:Emodin (Frangula emodin) is a selective 11β-HSD1 inhibitor,IC50 of 186 and 86 nM against 11β-HSD1 in humans and mice. High-Quality, Low-Cost!Fórmula:C15H10O5Pureza:98.37% - 99.53%Cor e Forma:Physical Description Orange Needles Or Powder (Ntp 1992)Peso molecular:270.24A-3 hydrochloride
CAS:<p>A-3 hydrochloride: potent, reversible kinase antagonist; permeable; inhibits PKC, CKI, PKA, CKII, MLCK; Ki: 4.3-80 μM.</p>Fórmula:C12H14Cl2N2O2SPureza:99.32%Cor e Forma:SolidPeso molecular:321.22WAY-297174
CAS:<p>WAY-297174 is a human protein kinase CK2 inhibitor with IC50 of > 33 μM.</p>Fórmula:C11H12N2O2S2Pureza:99.53%Cor e Forma:SoildPeso molecular:268.36GSK-3β/CK-1δ-IN-1
GSK-3β/CK-1δ-IN-1 (8d) is a dual inhibitor of GSK-3β and CK-1δ that can cross the blood-brain barrier, with IC50 values of 0.77 μM and 0.57 μM, respectively. GSK-3β/CK-1δ-IN-1 (8d) is applicable in neuroblastoma research.Fórmula:C22H17F3N4OCor e Forma:SolidPeso molecular:410.39Casein
CAS:Casein is a milk protein with multiple roles involved in novel drug delivery systems.Pureza:95%Cor e Forma:SoildCasein kinase 1δ-IN-9
CAS:<p>Casein kinase 1δ-IN-9 is a Quinone reductase 2 inhibitor with IC50 of 0.6μM.</p>Fórmula:C15H12ClN3Pureza:99.93%Cor e Forma:SolidPeso molecular:269.73AH081
AH081 (Compound 38) is a CK1δ/ε PROTAC degrader and serves as the negative control for AH078. It maintains inhibitory activity against CK1δ/ε but lacks degradation activity due to the use of an inactive stereoisomer of the VHL ligand.Cor e Forma:Odour SolidCSNK2-IN-2
CSNK2-IN-2 (compound 2) is an orally active inhibitor of CSNK2. It is utilized in antiviral research.Fórmula:C25H30FN9OCor e Forma:SolidPeso molecular:491.56CK1δ/CK1ε liagnd-1
CK1δ/CK1ε ligand-1 is a ligand of CK1δ/CK1ε and can serve as a target protein ligand for the synthesis of the CK1 PROTAC degrader AH078.Fórmula:C21H20F2N6Cor e Forma:SolidPeso molecular:394.42CK2-IN-14
CK2-IN-14 (Compound 10b) is an inhibitor of cyclin-dependent kinase 2α with an IC50 of 36.7 nM. It effectively hinders the growth of cancer cell lines 786-O and U937, with GI50 values of 7.3 μM and 7.5 μM, respectively.Fórmula:C19H20ClN5SCor e Forma:SolidPeso molecular:385.91Casein Kinase Substrates 3
CAS:Casein Kinase Substrates 3 is a substrate of casein kinase.Fórmula:C85H139N27O35SPureza:98%Cor e Forma:SolidPeso molecular:2131.24CK1-IN-4
CK1-IN-4 (Compound 59) is an inhibitor of casein kinase CK1δ with an IC50 of 2.74 μM. It exhibits neuroprotective activity in SH-SY5Y cells treated with Ethacrynic acid.Cor e Forma:Odour SolidCasein Kinase 2 Substrate Peptide
CAS:CK2 Substrate Peptide, C-terminus linked to EDANS, used for CK2 activity assays.Fórmula:C45H73N19O24Cor e Forma:SolidPeso molecular:1264.17AH078
AH078 (compound 37) is a selective PROTAC degrader targeting CK1δ and CK1ε with low selectivity for CK1α. AH078 consists of a PROTAC linker (black part) Monomethyl octanoate, a target protein ligand (red part) CK1δ/CK1ε ligand-1, and an E3 ligase ligand (blue part) E3 Ligase Ligand 58. The E3 ligase ligand combined with the linker forms the conjugate E3 Ligase Ligand-linker Conjugate 163.Fórmula:C51H60F2N10O5SCor e Forma:SolidPeso molecular:963.15QXG-6442
QXG-6442 is a molecular glue degrader targeting CK1α, demonstrating a degradation potency with a DC50 of 5.7 nM and a Dmax of 90%. In the MOLM-14 cell line, QXG-6442 induces antiproliferative effects.Fórmula:C21H17N5O4Cor e Forma:SolidPeso molecular:403.39Casein kinase 1δ-IN-6
CAS:CK1δ-IN-6: potent, selective CK-1δ inhibitor, IC50 23 nM, neuroprotective, anti-inflammatory, for neurodegenerative research.Fórmula:C16H10ClF3N2OSPureza:99.87%Cor e Forma:SoildPeso molecular:370.78Ellagic acid (hydrate)
CAS:Ellagic acid (hydrate) is a natural antioxidant and acts as a potent and ATP-competitive CK2 inhibitor (IC50:40 nM, Ki: 20 nM).Fórmula:C14H8O9Pureza:98%Cor e Forma:Green To Beige PowderPeso molecular:320.21Casein kinase 1δ-IN-15
CAS:Casein kinase 1δ-IN-15, an inhibitor for casein kinase 1 (CK1δ), exhibits an IC50 of 0.045 μM [1].Fórmula:C19H17FN6OCor e Forma:SolidPeso molecular:364.38Casein kinase 1δ-IN-14
CAS:Casein kinase 1δ-IN-14 (WAY-637081) can be used to study atherosclerosis-related cardiovascular disease.Fórmula:C17H11ClN4O2Pureza:99.66%Cor e Forma:SolidPeso molecular:338.75Casein kinase 1δ-IN-8
CAS:Casein kinase 1δ-IN-8 is an inhibitor of casein kinase 1δ and is used to treat neurodegenerative diseases such as Alzheimer's disease type.Fórmula:C19H14FN5OSPureza:99.56%Cor e Forma:SolidPeso molecular:379.41MU1742
MU1742 is a probe for CK1δ and CK1ε protein kinases [1] .Fórmula:C22H22F2N6Cor e Forma:SolidPeso molecular:408.45CK2-IN-13
CK2-IN-13 (compound 12c) is a potent inhibitor of CK2, with an IC50 value of 5.8 nM, playing a significant role in cancer research.Fórmula:C19H13Br2NO3Cor e Forma:SolidPeso molecular:463.119Casein kinase 1δ-IN-7
CAS:Casein kinase 1δ-IN-7 is a Casein kinase 1δ inhibitor for neurodegenerative diseases such as Alzheimer's disease.Fórmula:C17H14N4O2SPureza:98.02%Cor e Forma:SolidPeso molecular:338.38CK1-IN-3
CAS:WAY-296817 inhibits CK1, potential for circadian rhythm and inflammation research.Fórmula:C17H16N2O3SPureza:99.18%Cor e Forma:SolidPeso molecular:328.39Ref: TM-T60005
1mg35,00€5mg74,00€10mg101,00€25mg178,00€50mg258,00€100mg354,00€200mg485,00€1mL*10mM (DMSO)82,00€TBCA
CAS:TBCA: selective CK2 inhibitor, IC50=110 nM, Ki=77 nM, favors CK2 over CK1, DYRK1A, and 27 other kinases.Fórmula:C9H4Br4O2Pureza:99.3%Cor e Forma:SolidPeso molecular:463.74CK2-IN-15
CK2-IN-15 (Compound Biv5) is a selective and potent inhibitor of the enzyme protein kinase CK2, with an IC50 value of 51 pM. It significantly reduces the replication of SARS-CoV-2 in HEK-ACE2-TMPRSS2 and Vero cells, and also decreases viral replication in an in vitro model of human nasal epithelial cells. CK2-IN-15 holds potential for research into diseases related to β-coronavirus infections.Cor e Forma:Odour SolidCZP-IN-1
CZP-IN-1 (compound SH-1) is an inhibitor targeting the pathogen Trypanosoma cruzi protease (CZP) without affecting cathepsin L (IC50=28 nM). This compound is applicable in Chagas disease research.Fórmula:C20H26N4O4SCor e Forma:SolidPeso molecular:418.51Casein kinase 1δ-IN-3
CAS:<p>Casein kinase 1δ-IN-3 (Casein kinase 1δ-IN-3) (Compound 23a) is a casein kinase 1 delta (CK1d) inhibitor with a pIC50 of 6.5376 M.</p>Fórmula:C17H16N2O2SPureza:98.94%Cor e Forma:SoildPeso molecular:312.39SGC-CK2-1
CAS:SGC-CK2-1, a CK2 inhibitor, is a inducer of insulin production and secretion in pancreatic β-cells.Fórmula:C20H21N7OPureza:99.41%Cor e Forma:SolidPeso molecular:375.43MRT00033659
CAS:MRT00033659 inhibits CK1 (IC50=0.9 μM), CHK1 (IC50=0.23 μM), activates p53, and destabilizes E2F-1; it's a pyrazolo-pyridine.Fórmula:C15H14N4OCor e Forma:SolidPeso molecular:266.3PF-5006739
CAS:PF-5006739: potent, selective CK1δ/ε inhibitor (IC50: 3.9/17.0 nM); may treat psychiatric disorders, improves glucose tolerance, reduces opioid seeking.Fórmula:C22H22FN7OPureza:98%Cor e Forma:SolidPeso molecular:419.45FPFT-2216
CAS:FPFT-2216 is a "molecular glue" compound with potential anti-tumor activity that degrades IKZF6, IKZF1, DE1D and can be used to study immune system diseases.Fórmula:C12H12N4O3SPureza:99.35% - 99.62%Cor e Forma:SolidPeso molecular:292.31Ref: TM-T60608
1mg92,00€5mg222,00€10mg334,00€25mg708,00€50mg1.108,00€100mg1.783,00€200mg2.412,00€1mL*10mM (DMSO)236,00€TTP 22
CAS:TTP 22: ATP-competitive CK2 inhibitor; IC50/Ki: 0.1 μM/40 nM; >250x selective over JNK3, ROCK1, MET.Fórmula:C16H14N2O2S2Pureza:97.08% - 97.78%Cor e Forma:SolidPeso molecular:330.42Silmitasertib
CAS:Silmitasertib (CX-4945) is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).Fórmula:C19H12ClN3O2Pureza:98% - 99.90%Cor e Forma:SolidPeso molecular:349.77Ref: TM-T2259
1mg40,00€2mg51,00€5mg85,00€10mg125,00€25mg207,00€50mg329,00€100mg520,00€500mg1.111,00€1mL*10mM (DMSO)93,00€CK1-IN-1
CAS:CK1-IN-1, a CK1 inhibitor with IC50: 15nM CK1δ, 16nM CK1ε, 73nM p38σ; patent WO2015119579A1.Fórmula:C24H15F2N3Pureza:98.79%Cor e Forma:SolidPeso molecular:383.39Ref: TM-T5393
1mg49,00€2mg65,00€5mg97,00€10mg160,00€25mg305,00€50mg472,00€100mg707,00€1mL*10mM (DMSO)106,00€TBB
CAS:<p>TBB (NSC-231634)(NSC-231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2).</p>Fórmula:C6HBr4N3Pureza:98.51% - 99.45%Cor e Forma:Off-White SolidPeso molecular:434.71DMAT
CAS:DMAT (Casein kinase II Inhibitor) is a potent and specific inhibitor of CK2(IC50 value of 130 nM).Fórmula:C9H7Br4N3Pureza:99.48%Cor e Forma:SolidPeso molecular:476.79Longdaysin
CAS:Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).Fórmula:C16H16F3N5Pureza:99.97%Cor e Forma:SolidPeso molecular:335.33PF-670462
CAS:PF-670462 is a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 additional kinases) inhibitor of CK1ε in isolated enzyme preparations.Fórmula:C19H22Cl2FN5Pureza:99.42% - 99.72%Cor e Forma:SolidPeso molecular:410.32TA-01
CAS:TA-01 is a potent CK1 and p38 MAPK inhibitor, with IC50s of 6.4 nM, 6.8 nM, 6.7 nM for CK1ε, CK1δ and p38 MAPK, respectively.Fórmula:C20H12F3N3Pureza:99.55% - 99.94%Cor e Forma:SolidPeso molecular:351.32Ref: TM-T4645
2mg34,00€5mg50,00€10mg80,00€25mg147,00€50mg224,00€100mg313,00€200mg439,00€1mL*10mM (DMSO)67,00€Epiblastin A
CAS:Epiblastin A inhibits CK1, targets its isoenzymes, and converts EpiSCs to cESCs.Fórmula:C12H10ClN7Pureza:99.45%Cor e Forma:SolidPeso molecular:287.71IWP-2
CAS:IWP-2 is a Wnt pathway inhibitor and an ATP-competitive CK1δ inhibitor. IWP-2 inhibits self-renewal of embryonic stem cells. Cost effective and quality assured.Fórmula:C22H18N4O2S3Pureza:96.1% - 99.49%Cor e Forma:SolidPeso molecular:466.6CKI-7 free base
CAS:CKI-7 free base is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor.Fórmula:C11H12ClN3O2SCor e Forma:SolidPeso molecular:285.75IC261
CAS:IC261 (SU-5607) is a novel inhibitor of CK1, triggers the mitotic checkpoint control. The IC50 of IC261 for CK1 was 16 μM and for Cdk5 is 4.5 mM.Fórmula:C18H17NO4Pureza:99.45% - 99.91%Cor e Forma:SolidPeso molecular:311.33LY-294002 hydrochloride
CAS:LY-294002 HCl (NSC 697286) is a stable PI3K inhibitor (IC50: 0.5-0.97 µM) and prevents autophagosome formation.Fórmula:C19H17NO3·HClPureza:99.95% - 99.98%Cor e Forma:SolidPeso molecular:343.81LH846
CAS:LH846 is a selective inhibitor of CK1δ (IC50 values are 290 nM, 1.3 uM and 2.5 uM for CK1δ, ε and α); exhibits no inhibitory activity at CK2.Fórmula:C16H13ClN2OSPureza:90% - 98.26%Cor e Forma:SolidPeso molecular:316.81PF-4800567
CAS:PF-4800567 is a selective inhibitor of casein kinase 1ε (CK1ε; IC50 = 32 nM) with greater than 20-fold selectivity over CK1δ.Fórmula:C17H18ClN5O2Pureza:99.74% - 99.76%Cor e Forma:SolidPeso molecular:359.81Orobol
CAS:Orobol (3’,4’,5,7-tetrahydroxy-isoflavon) is an inhibitor of tyrosine-specific protein kinase and phosphatidylinositol turnover.Fórmula:C15H10O6Pureza:98% - 98%Cor e Forma:SolidPeso molecular:286.24D4476
CAS:D4476 (Casein Kinase I Inhibitor) is an effective, selective, and cell-permeant CK1 (casein kinase 1) inhibitor( IC50=300 nM in a cell-free assay).Fórmula:C23H18N4O3Pureza:99.7% - 99.96%Cor e Forma:SolidPeso molecular:398.41AS-252424
CAS:AS-252424 is a potent and selective inhibitor of PI3Kγ with IC50 of 33 nM; >10 fold selectivity for PI3Kγ versus PI3Kα.Fórmula:C14H8FNO4SPureza:99.06% - 99.09%Cor e Forma:SolidPeso molecular:305.28Ref: TM-T6208
1mg37,00€2mg52,00€5mg77,00€10mg128,00€25mg205,00€50mg309,00€100mg447,00€500mg973,00€1mL*10mM (DMSO)84,00€(E/Z)-GO289
CAS:<p>(E/Z)-GO289, which strongly lengthened circadian period, is a potent and selective inhibitor of CK2.</p>Fórmula:C17H15BrN4O2SPureza:98.1%Cor e Forma:SolidPeso molecular:419.3Umbralisib
CAS:Umbralisib (TGR 1202) is a PI3Kδ inhibitor.Fórmula:C31H24F3N5O3Pureza:99.56% - 99.56%Cor e Forma:White SolidPeso molecular:571.55Ref: TM-T4976
1mg48,00€2mg65,00€5mg96,00€10mg170,00€25mg343,00€50mg449,00€100mg658,00€1mL*10mM (DMSO)120,00€Umbralisib hydrochloride
CAS:Umbralisib hydrochloride: PI3Kδ inhibitor; IC50=22.2 nM, EC50=24.3 nM; active vs CK1ε, EC50=6.0 μM.Fórmula:C31H25ClF3N5O3Pureza:98%Cor e Forma:SolidPeso molecular:608.01NCC007
CAS:NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin.Fórmula:C22H28F3N7Pureza:98.88%Cor e Forma:SolidPeso molecular:447.5CKI-7
CAS:CKI-7 is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor.Fórmula:C11H14Cl3N3O2SPureza:>99.99%Cor e Forma:SolidPeso molecular:358.67Ref: TM-T19913
1mg114,00€5mg217,00€10mg325,00€25mg525,00€50mg712,00€100mg959,00€200mg1.293,00€1mL*10mM (DMSO)239,00€SR-3029
CAS:SR-3029 is a potent and highly specific CK1δ/CK1ε inhibitor.Fórmula:C23H19F3N8OPureza:99.64%Cor e Forma:SolidPeso molecular:480.45TAK-715
CAS:TAK-715 is a p38 MAPK inhibitor for p38α.Fórmula:C24H21N3OSPureza:99.83%Cor e Forma:SolidPeso molecular:399.51Ref: TM-T6150
1mg40,00€2mg52,00€5mg87,00€10mg99,00€25mg170,00€50mg324,00€100mg507,00€1mL*10mM (DMSO)96,00€LY294002
CAS:LY294002 (SF 1101) is a broad-spectrum inhibitor of PI3K, inhibiting PI3Kα, PI3Kδ, and PI3Kβ (IC50=0.5/0.57/0.97 μM).Fórmula:C19H17NO3Pureza:98% - 99.96%Cor e Forma:Pale Yellow SolidPeso molecular:307.34XL413
CAS:XL-413 is an oral CDC7 kinase inhibitor, potentially blocking DNA replication, mitosis, and cancer cell growth.Fórmula:C14H12ClN3O2Pureza:98.40% - 99.94%Cor e Forma:SolidPeso molecular:289.72Umbralisib sulfate
CAS:Umbralisib sulfate, an oral dual PI3Kδ/CK1ε inhibitor (EC50: 22.2 nM/6.0 μM), targets CLL T cells for blood cancer research.Fórmula:C31H26F3N5O7SCor e Forma:SolidPeso molecular:669.63Umbralisib tosylate
CAS:Umbralisib tosylate, an oral PI3Kδ/CK1ε inhibitor (EC50: 22.2 nM/6.0 μM), shows promise for CLL research.Fórmula:C38H32F3N5O6SCor e Forma:SolidPeso molecular:743.75IQA
CAS:IQA is a casein kinase 2 (CK2) inhibitor.Fórmula:C17H12N2O3Cor e Forma:SolidPeso molecular:292.29CK1-IN-2
CAS:CK1-IN-2 (compound Nr.4) is a potent CK1 inhibitor p38a, and is used in DUX4 overexpression-associated diseases, such as muscular dystrophy.Fórmula:C17H12FN3O2Pureza:99.31%Cor e Forma:SolidPeso molecular:309.29CK2α-IN-1
CAS:CK2α-IN-1 is a selective non-ATP-competitive CK2α inhibitor with an IC50 of 7.0 µM and a Ki of 1.6 µM.CK2α-IN-1 exhibits potential anticancer activity and canFórmula:C16H11N3O4SPureza:98%Cor e Forma:SolidPeso molecular:341.34BTX161
CAS:BTX161: potent CKIα degrader, surpasses Lenalidomide in AML, triggers DDR + p53, stabilizes MDM2.Fórmula:C15H16N2O3Cor e Forma:SolidPeso molecular:272.3PF 4800567 hydrochloride
CAS:casein kinase 1ε inhibitorFórmula:C17H19Cl2N5O2Pureza:98%Cor e Forma:SolidPeso molecular:396.27SSTC3
CAS:SSTC3 is a casein kinase 1α (CK1α) activator with potential antitumor activity that inhibits WNT signaling.Fórmula:C23H17F3N4O3S2Pureza:98.65% - 99.94%Cor e Forma:SolidPeso molecular:518.53Ref: TM-T13004
1mg99,00€5mg235,00€10mg376,00€25mg615,00€50mg867,00€100mg1.159,00€1mL*10mM (DMSO)238,00€CK2-IN-4
CAS:CK2-IN-4 is a protein kinase (CK2) inhibitor with an IC50 value of 8.6 µM.Fórmula:C18H11N3O4SPureza:99.65%Cor e Forma:SolidPeso molecular:365.36Tyrphostin AG 1112
CAS:Tyrphostin AG 1112 is a Bcr-Abl kinase blocker. It can activate the terminal differentiation of K562 cells and the purging of Ph+ cells.Fórmula:C15H10N6Cor e Forma:SolidPeso molecular:274.28Quinalizarin
CAS:Quinalizarin, the most selective CK2 inhibitor, is superior to CX-4945 which is the first-in-class CK2 inhibitor.Fórmula:C14H8O6Pureza:98%Cor e Forma:SolidPeso molecular:272.21SR-1277
CAS:SR-1277 is a potent, highly selective and ATP-competitive CK1δ/ε inhibitor, regulating Wee1 activity at the G2/M cell-cycle interface, and antiproliferative.Fórmula:C21H19N9O3SCor e Forma:SolidPeso molecular:477.5Ref: TM-T38927
1mg320,00€5mg747,00€10mg1.121,00€25mg1.833,00€50mg2.460,00€100mg3.353,00€1mL*10mM (DMSO)A consultarCK2-IN-9
CAS:CK2-IN-9, a potent and selective CK2 kinase inhibitor, exhibits an inhibitory concentration (IC50) of 3 nM against its target enzyme and hampers Wnt reporterFórmula:C23H29N9OCor e Forma:SolidPeso molecular:447.54HDAC/CK2-IN-1
CAS:HDAC/CK2-IN-1 (compound 38) acts as an inhibitor of HDAC1 (IC 50 = 1.46 μM), HDAC6 (IC 50 = 0.66 μM), and CK2 (IC 50 = 3.67 μM). It demonstrates promising antiproliferative effects on various cell lines, including Jurkat, MCF-7, HCT-116, and HL-60.Fórmula:C15H18Br4N4O2Cor e Forma:SolidPeso molecular:605.954,5,6,7-Tetrabromobenzimidazole
CAS:4,5,6,7-Tetrabromobenzimidazole is a selective and ATP-competitive inhibitor of protein kinase CK2 [1].Fórmula:C7H2Br4N2Cor e Forma:SolidPeso molecular:433.72AMG-548
CAS:AMG-548, oral p38α inhibitor (Ki=0.5 nM), >1000x selectivity over p38γ/δ, blocks TNFα (IC50=3 nM), also inhibits Wnt/Casein kinase 1δ/ε.Fórmula:C29H27N5OPureza:99.91%Cor e Forma:SolidPeso molecular:461.56CK2/PIM1-IN-1
CAS:CK2/PIM1-IN-1 inhibits CK2 & PIM1 (IC50s: 3.787 & 4.327 μM), aimed for cancer research.Fórmula:C15H9NO4S2Pureza:98%Cor e Forma:SolidPeso molecular:331.37(R)-DRF053 dihydrochloride
CAS:cdk/CK1 inhibitor,potent and ATP-competitiveFórmula:C23H29Cl2N7OPureza:98%Cor e Forma:SolidPeso molecular:490.43SRPIN-803
CAS:SRPIN-803 is a selective dual SRPK1 and CK2 inhibitor.Fórmula:C14H9F3N4O3SPureza:98%Cor e Forma:SolidPeso molecular:370.31CK2-IN-6
CAS:CK2-IN-6: Potent CK2 inhibitor for cancer, inflammation, pain, and immune research.Fórmula:C19H16ClN7O2Cor e Forma:SolidPeso molecular:409.83XL413 xHCl
CAS:<p>BMS-863233 HCl is an ATP-competitive Cdc7 inhibitor (IC50: 3.4 nM) that is potent and selective.BMS-863233 HCl inhibited CK2 and PIM1 with IC50 values of 215</p>Fórmula:C14H12ClN3O2·xHClPureza:99.37% - 99.67%Cor e Forma:SolidPeso molecular:326.18Casein kinase 1δ-IN-1
CAS:Casein kinase 1δ-IN-1 (WAY-643895) is an inhibitor of casein kinase 1δ (CK1δ), which inhibits CK1δ.Fórmula:C11H7N3OSPureza:99.89%Cor e Forma:SolidPeso molecular:229.26BioE-1115
CAS:BioE-1115 is a selective and potent inhibitor of serine-threonine protein kinase (PASK, IC50 = 4 nM). BioE-1115 is a potent inhibitor of CK2α (IC50 = 10 μM).Fórmula:C19H18FN3O2Pureza:97.54%Cor e Forma:SolidPeso molecular:339.36HS-276
CAS:HS-276, a selective oral TAK1 inhibitor (Ki: 2.5 nM), also targets CLK2, GCK, ULK2, MAP4K5; potential for RA research.Fórmula:C24H29N5O2Pureza:97.67% - 98.81%Cor e Forma:SolidPeso molecular:419.52Ref: TM-T62209
1mg66,00€5mg144,00€10mg219,00€25mg430,00€50mg690,00€100mg1.064,00€200mg1.434,00€1mL*10mM (DMSO)170,00€PI-828
CAS:PI-828 (LY 294002), a PI3K inhibitor, researches PI3K function and aids stem cell differentiation into mesoderm.Fórmula:C19H18N2O3Pureza:99.95%Cor e Forma:SolidPeso molecular:322.36Ref: TM-T16528
1mg35,00€5mg78,00€10mg117,00€25mg197,00€50mg283,00€100mg386,00€200mg550,00€1mL*10mM (DMSO)55,00€TID43
CAS:TID43, a CK2 inhibitor, exhibits potent inhibition with an IC50 value of 0.3 μM. It is applicable in anti-angiogenic research [1].Fórmula:C10H3I4NO4Cor e Forma:SolidPeso molecular:708.755PF-05236216
CAS:PF-05236216 is a potent, selective, brain-penetrant CK1δ/ε inhibitor that modulates circadian rhythms in mice, supporting sleep and metabolic research.Fórmula:C18H15FN4OPureza:100% - 100%Cor e Forma:SolidPeso molecular:322.34Casein kinase 1δ-IN-4
CAS:"Casein kinase 1δ-IN-4 (compound 567) is a potent inhibitor of casein kinase 1δ with potential application in Alzheimer's disease research [1]."Fórmula:C16H12N6SPureza:98%Cor e Forma:SolidPeso molecular:320.37XL413 hydrochloride
CAS:XL413 hydrochloride (BMS-863233 Hydrochloride) is a potent, selective and ATP competitive inhibitor of Cdc7. XL413 hydrochloride also inhibits CK2 and PIM1.Fórmula:C14H13Cl2N3O2Pureza:98.81% - 99.8%Cor e Forma:SolidPeso molecular:326.18Ref: TM-T6735
1mg50,00€5mg109,00€10mg152,00€25mg268,00€50mg447,00€100mg672,00€200mg888,00€500mg1.369,00€BAY-204
CAS:BAY-204 is a CSNK1α/δ inhibitor that can be used in the treatment of proliferative diseases.Fórmula:C29H26F3N5O2Cor e Forma:SolidPeso molecular:533.54Ac-VDVAD-CHO
CAS:Ac-VDVAD-CHO is an inhibitor of caspase-2 and caspase-3 (IC50: 46 nM for caspase-2 and 15 nM for caspase-3) [1].Fórmula:C23H37N5O10Pureza:98%Cor e Forma:SolidPeso molecular:543.57ON 108600
CAS:ON 108600 is a chemical inhibitor targeting CK2 (Casein Kinase 2), TNIK, and DYRK1, demonstrating IC50 values of 0.016 μM and 0.007 μM for DYRK1A and DYRK1B, 0.Fórmula:C22H14Cl2N2O6S2Pureza:98%Cor e Forma:SolidPeso molecular:537.39Casein kinase 1δ-IN-5
CAS:Casein kinase 1δ-IN-5 is a potent and selective CK-1δ inhibitor, exhibiting an IC50 of 47 nM, and demonstrates neuroprotective and anti-inflammatory effects inFórmula:C16H11F3N2OSPureza:98%Cor e Forma:SolidPeso molecular:336.33Casein kinase 1δ-IN-10
CAS:Casein kinase 1δ-IN-10 is an inhibitor of casein kinase 1δ (CK1δ).Fórmula:C21H17N3O3Pureza:98%Cor e Forma:SolidPeso molecular:359.38Casein Kinase II Inhibitor IV
CAS:Casein kinase II inhibitor IV is an effective small molecule inducer, which can be used to induce epidermal keratinocyte differentiation.Fórmula:C24H23N5O3Pureza:99.65% - 99.75%Cor e Forma:SolidPeso molecular:429.47Ref: TM-T10687
1mg87,00€5mg170,00€10mg259,00€25mg429,00€50mg605,00€100mg815,00€500mg1.624,00€1mL*10mM (DMSO)180,00€Dinoxyline
CAS:Dinoxyline is a potent dopamine receptor agonist, with dissociation constants (Ki values) for D1, D2, D3, and D4 receptors being 7 nM, 6 nM, 5 nM, and 43 nM, respectively. It is utilized in neuroscience research.Fórmula:C15H13NO3Cor e Forma:SolidPeso molecular:255.27
